83rd Scientific Sessions | American Diabetes Association

There are companies that are claiming to offer registration services for ADA’s Scientific Sessions, which are not affiliated with ADA and do not offer any servi ces on our behalf. Registration should only be accessed from the ADA website. If you do not see this logo on the website then they are not our official provider! If you were unable to attend the American Diabetes Association 83rd Scientific Sessions, it’s not too late to access over 800 presentations highlighting the most exciting science in

Read the full article here

Source: professional.diabetes.org

Categories: Endocrinology, General Medicine News

Tweets with this article

ADA DiabetesPro

The 84th Scientific Sessions is seeking high-quality, innovative session proposals to enhance next year's event. This is your chance to contribute to the scientific program and showcase the latest advancements. Submit your proposals by August 14, 2023! https://t.co/yIQNrh28L6 https://t.co/sWI4Igt5eI

FDA approves new indication for Ozempic to lower kidney risks in type 2 diabetes, CKD

The FDA has approved a new indication for semaglutide to lower the risk for worsening kidney disease, kidney failure and cardiovascular death among adults with…

Endocrine Today January 31, 2025

Call for Abstracts

There is no better place to share your research than ENDO, the Endocrine Society’s annual meeting. Submitting an abstract earns media coverage for your work,…

Endocrine News January 30, 2025

Recognized Leader in Caring for People Living with Diabetes

The Leapfrog Group and the American Diabetes Association (ADA) partnered to launch an inpatient diabetes recognition program called Recognized Leader in Caring for People Living…

ADA DiabetesPro January 30, 2025

Type 1 Diabetes | ADA

Get all the information on type 1 diabetes you need to better help the people you treat.

ADA DiabetesPro January 30, 2025

On-Demand Education – The Obesity Society

On-Demand Education: Science from The Obesity Society The Obesity Society (TOS) on-demand education is a great way to gain an in-depth understanding of essential aspects…

The Obesity Society January 30, 2025

Transforming Lives with Action | ADA

Find out how our advocacy supports diabetes research funding, health care access. Become an advocate and help us ensure a bright future for those living…

Amer. Diabetes Assn. January 30, 2025

Editorial for January/February Issue of AACE Clinical Case Reports

Happy New Year and welcome to another issue of AACE Clinical Case Reports (ACCR)!

AACE January 30, 2025

Insights into the genetic landscape of pheochromocytomas and paragangliomas in a Brazilian cohort

AbstractObjective. Germline and somatic drivers are identified in 30% and 40% of pheochromocytomas and paragangliomas (PPGLs), respectively. In this study,

Euro J Endocrinology January 30, 2025

Thyroidectomy without radioiodine in patients with low-risk thyroid cancer: 5 years of follow-up of the prospective randomised ESTIMABL2 trial

The non-inferiority of a follow-up strategy compared with postoperative 131I administration in low risk differentiated thyroid cancer was confirmed at 5 years. There is no…

The Lancet Diabetes & Endocrinology January 30, 2025

Daily metformin prevents type 2 diabetes among patients with metabolic syndrome

Participants with metabolic syndrome who received 1,700 mg metformin daily with or without a Mediterranean diet intervention had reduced incidence of diabetes compared with placebo,…

Endocrine Today January 30, 2025

Related Articles